Appearance and Shape (20°C) | Solid |
---|---|
CAS RN | 17902-23-7 |
MDL number | MFCD00012351 |
Molecular weight | 200.17 |
Molecular Formula | C8H9FN2O3 |
Product code | ICTF0635 |
PubChem Substance ID | 87559743 |
Purity/Analytical Methods | >98.0%(HPLC)(N) |
Reaxys-RN | 525766 |
Appearance | White to Almost white powder to crystal |
---|
Pictograms | |
---|---|
Hazard statement | H300 : Fatal if swallowed H373 : May cause damage to organs through prolonged or repeated exposure. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant P260 : Do not breathe dust/ fume/ gas/ mist/ vapors/ spray P270 : Do not eat, drink or smoke when using this product P264 : Wash skin thoroughly after handling P314 : Get medical advice/ attention if you feel unwell P301 + P310 + P330 : IF SWALLOWED: Immediately call a POISON CENTER/doctor. Rinse mouth P405 : Store locked up. |
Signal word | Danger |
RTECS# | YR0450000 |
---|
Category | 6.1 |
---|---|
Packaging category | II |
UN number | UN2811 |
Chemicals by Class 5-Membered Heterocyclic Compounds [Chemical Structural Class] Tetrahydrofurans [Chemical Structural Class] 6-Membered Heterocyclic Compounds [Chemical Structural Class] Pyrimidines [Chemical Structural Class] Uracils [Chemical Structural Class]
Chemistry Pharmaceutical Development and Drug Discovery Research Reagents Drug Delivery Systems (DDS) Prodrug Ingredients
Life Science Biochemicals and Reagents Nucleosides, Nucleotides, Oligonucleotides Nucleoside Analogs Nucleosides Pyrimidine Nucleoside Analogs Pyrimidine Nucleosides Pharmaceutical Ingredients (for Research and Experimental Use) Antitumor Antimetabolites Antitumor Ingredients (for Research and Experimental Use) Pharmaceutical Development and Drug Discovery Research Drug Delivery Systems (DDS) Prodrug Ingredients Pharmaceutical Ingredients (for Research and Experimental Use) Antitumor Antimetabolites Antitumor Ingredients (for Research and Experimental Use)